Gelnique (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Gelnique drug offered from Actavis Pharma, Inc.. This Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Oxybutynin |
SUBSTANCE NAME: | OXYBUTYNIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cholinergic Muscarinic Antagonist [EPC],Cholinergic Muscarinic Antagonists [MoA] |
ROUTE: | TRANSDERMAL |
DOSAGE FORM: | GEL |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-04-02 |
END MARKETING DATE: | 0000-00-00 |
Gelnique HUMAN PRESCRIPTION DRUG Details:
Item Description | Gelnique from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 28(mg/.92g) |
START MARKETING DATE: | 2012-04-02 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 52544-041_eab01b57-bd14-4f36-9a81-f63d250fd132 |
PRODUCT NDC: | 52544-041 |
APPLICATION NUMBER: | NDA202513 |
Other OXYBUTYNIN Pharmaceutical Manufacturers / Labelers: